Cat. #151507
Anti-IFITM3 [IFITM3]
Cat. #: 151507
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: Interferon-induced Transmembrane protein 3
Class: Polyclonal
Application: WB
Reactivity: Human
Host: Rabbit
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Elisabeth Trivier
Institute: Cancer Research Technology
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-IFITM3 [IFITM3]
- Research fields: Developmental biology;Stem cell biology
- Clone: IFITM3
- Tool sub type: Primary antibody
- Class: Polyclonal
- Conjugation: Unconjugated
- Reactivity: Human
- Host: Rabbit
- Application: WB
- Description: Analyses of gene expression of IFN-inducible transmembrane protein (IFITM) levels revealed high levels of expression in early and late intestinal neoplasm in both mice and humans. IFITM gene expression is rapidly induced after activation of the -catenin signalling and expression is significantly up-regulated specifically in colorectal tumors and thus may be a useful diagnostic tool in these tumors.
- Immunogen: PVNSGQPPNYEMLKEEHEVA
Target Details
- Target: Interferon-induced Transmembrane protein 3
- Target background: Analyses of gene expression of IFN-inducible transmembrane protein (IFITM) levels revealed high levels of expression in early and late intestinal neoplasm in both mice and humans. IFITM gene expression is rapidly induced after activation of the -catenin signalling and expression is significantly up-regulated specifically in colorectal tumors and thus may be a useful diagnostic tool in these tumors.
Applications
- Application: WB
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage conditions: -15° C to -25° C
- Shipping conditions: Dry ice
